Abbonarsi

Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura disease - 04/08/22

Doi : 10.1016/j.jaci.2022.03.034 
Ryusuke Munemura, DDS a, Takashi Maehara, DDS, PhD a, j, , Yuka Murakami, DDS a, Risako Koga, DDS a, Ryuichi Aoyagi, DDS a, Naoki Kaneko, DDS, PhD a, Atsushi Doi, PhD b, Cory A. Perugino, DO c, d, Emanuel Della-Torre, MD e, Takako Saeki, MD f, Yasuharu Sato, DDS, PhD g, Hidetaka Yamamoto, MD, PhD h, Tamotsu Kiyoshima, DDS, PhD i, John H. Stone, MD, MPH c, Shiv Pillai, MBBS, PhD d, Seiji Nakamura, DDS, PhD a
a Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan 
b Cell Innovator Inc, Fukuoka, Japan 
c Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass 
d Ragon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Harvard Medical School, Boston, Mass 
e Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy 
f Department of Internal Medicine, Nagaoka Red Cross Hospital, Nagaoka, Japan 
g Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan 
h Division of Diagnostic Pathology, Kyushu University Hospital, Fukuoka, Japan 
i Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan 
j Dento-craniofacial Development and Regeneration Research Center, Faculty of Dental Science, Kyushu University, Fukuoka, Japan 

Corresponding author: Takashi Maehara, DDS, PhD, Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.Section of Oral and Maxillofacial OncologyDivision of Maxillofacial Diagnostic and Surgical SciencesFaculty of Dental ScienceKyushu UniversityFukuokaJapan

Abstract

Background

How T follicular (Tfh) cells contribute to many different B-cell class-switching events during T-cell–dependent immune responses has been unclear. Diseases with polarized isotype switching offer a unique opportunity for the exploration of Tfh subsets. Secondary and tertiary lymphoid organs in patients with elevated tissue expression levels of IgE (Kimura disease, KD) and those of IgG4 (IgG4-related disease, IgG4-RD) can provide important insights regarding cytokine expression by Tfh cells.

Objective

We sought to identify disease-specific Tfh cell subsets in secondary and tertiary lymphoid organs expressing IL-10 or IL-13 and thus identify different cellular drivers of class switching in 2 distinct types of fibrotic disorders: allergic fibrosis (driven by type 2 immune cells) and inflammatory fibrosis (driven by cytotoxic T lymphocytes).

Methods

Single-cell RNA sequencing, in situ sequencing, and multicolor immunofluorescence analysis were used to investigate B cells, Tfh cells, and infiltrating type 2 cells in lesion tissues from patients with KD or IgG4-RD.

Results

Infiltrating Tfh cells in tertiary lymphoid organs from IgG4-RD were divided into 6 main clusters. We encountered abundant infiltrating IL-10–expressing LAG3+ Tfh cells in patients with IgG4-RD. Furthermore, we found that infiltrating AICDA+CD19+ B cells expressing IL-4, IL-10, and IL-21 receptors correlated with IgG4 expression. In contrast, we found that infiltrating IL-13–expressing Tfh cells were abundant in affected tissues from patients with KD. Moreover, we observed few infiltrating IL-13–expressing Tfh cells in tissues from patients with IgG4-RD, despite high serum levels of IgE (but low IgE in the disease lesions). Cytotoxic T cells were abundant in IgG4-RD; in contrast, type 2 immune cells were abundant in KD.

Conclusions

Our analysis revealed a novel subset of IL-10+LAG3+ Tfh cells infiltrating the affected organs of IgG4-RD patients. In contrast, IL-13+ Tfh cells and type 2 immune cells infiltrated those of KD patients.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Il testo completo di questo articolo è disponibile in PDF.

Key words : Single-cell RNA sequencing, IgG4-related disease, IgG4-RD, IgG4, IgE, Tfh cell, B cell, interleukin-10, class switch, fibrosis

Abbreviations used : CS, cTfh, CTL, DAPI, IgG4-RD, ILC2, KD, OPN, scRNA-Seq, SjS, SLO, Tfh, Tfh13, Tfr, TLO, t-SNE


Mappa


 The first 2 authors contributed equally to this article, and both should be considered first author.
 This study was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (grants JP18KK0260, 21K19607, and JP19H03854), the Kanae Foundation for the Promotion of Medical Science, the R3QR program (Qdai-jump research program 01216), and the Takeda Science Foundation) (all to T.M.) and by JSPS KAKENHI grant JP20H00553 (to S.N.). S.P. was supported by National Institutes of Health grant U19 AI110495. C.A.P. was supported by a Rheumatology Research Foundation Scientist Development Award.
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2022  American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 150 - N° 2

P. 440 - Agosto 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • A mouse model of the LEAP study reveals a role for CTLA-4 in preventing peanut allergy induced by environmental peanut exposure
  • James W. Krempski, Jyoti K. Lama, Koji Iijima, Takao Kobayashi, Mayumi Matsunaga, Hirohito Kita
| Articolo seguente Articolo seguente
  • Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
  • Linlin Yang, Claire Booth, Carsten Speckmann, Markus G. Seidel, Austen J.J. Worth, Gerhard Kindle, Arjan C. Lankester, Bodo Grimbacher, ESID Clinical and Registry Working Parties, Andrew R. Gennery, Mikko R.J. Seppanen, Emma C. Morris, Siobhan O. Burns, Anna Sediva, Benedicte Neven, Fabian Hauck, Klaus Warnatz, Malgorzata Pac, Maria Carrabba, Pere Palacin, Peter Jandus, Ann Gardulf, Nizar Mahlaoui, Martine Pergent, Catharina Schutz, Svetlana Sharapova, Lougaris Vassilios, Fabio Candotti, Stephano Volpi

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.